Marketable Securities, Current in USD of ProPhase Labs, Inc. from Q3 2017 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of investment in marketable security, classified as current.
Summary
ProPhase Labs, Inc. quarterly Marketable Securities, Current history and change rate from Q3 2017 to Q4 2024.
  • ProPhase Labs, Inc. Marketable Securities, Current for the quarter ending 31 Dec 2024 was $0.000, a 100% decline year-over-year.
Marketable Securities, Current, Quarterly (USD)
Marketable Securities, Current, YoY Quarterly Change (%)

ProPhase Labs, Inc. Quarterly Marketable Securities, Current (USD)

Period Value YoY Chg Change % Date Report Filed
Q4 2024 $0 -$3.13M -100% 31 Dec 2024 10-K 01 Apr 2025
Q3 2024 $2K* -$2.56M 30 Sep 2024 10-Q 13 Nov 2024
Q2 2024 $1K* -$5.28M 30 Jun 2024 10-Q 14 Aug 2024
Q1 2024 $58K -$5.89M -99% 31 Mar 2024 10-Q 10 May 2024
Q4 2023 $3.13M -$5.2M -62.5% 31 Dec 2023 10-K 01 Apr 2025
Q3 2023 $2.57M -$1.11M -30.3% 30 Sep 2023 10-Q 13 Nov 2023
Q2 2023 $5.28M +$1.74M +49.2% 30 Jun 2023 10-Q 11 Aug 2023
Q1 2023 $5.95M +$2.4M +67.8% 31 Mar 2023 10-Q 12 May 2023
Q4 2022 $8.33M -$451K -5.14% 31 Dec 2022 10-K 29 Mar 2024
Q3 2022 $3.68M -$10.4M -73.9% 30 Sep 2022 10-Q 10 Nov 2022
Q2 2022 $3.54M -$14.6M -80.4% 30 Jun 2022 10-Q 12 Aug 2022
Q1 2022 $3.54M +$12K +0.34% 31 Mar 2022 10-Q 13 May 2022
Q4 2021 $8.78M +$7.14M +436% 31 Dec 2021 10-K 29 Mar 2023
Q3 2021 $14.1M +$12.7M +906% 30 Sep 2021 10-Q 12 Nov 2021
Q2 2021 $18.1M +$14.8M +442% 30 Jun 2021 10-Q 13 Aug 2021
Q1 2021 $3.53M +$2.69M +320% 31 Mar 2021 10-Q 14 May 2021
Q4 2020 $1.64M +$713K +77% 31 Dec 2020 10-K 31 Mar 2022
Q3 2020 $1.4M -$2.36M -62.7% 30 Sep 2020 10-Q 19 Nov 2020
Q2 2020 $3.34M -$1.35M -28.7% 30 Jun 2020 10-Q 11 Aug 2020
Q1 2020 $840K -$3.39M -80.1% 31 Mar 2020 10-Q 12 May 2020
Q4 2019 $926K -$5.76M -86.2% 31 Dec 2019 10-K 31 Mar 2021
Q3 2019 $3.76M -$3.11M -45.2% 30 Sep 2019 10-Q 12 Nov 2019
Q2 2019 $4.69M -$2.09M -30.9% 30 Jun 2019 10-Q 12 Aug 2019
Q1 2019 $4.23M -$14.1M -76.9% 31 Mar 2019 10-Q 14 May 2019
Q4 2018 $6.69M -$12.1M -64.4% 31 Dec 2018 10-K 26 Mar 2020
Q3 2018 $6.87M -$16.8M -71% 30 Sep 2018 10-Q 14 Nov 2018
Q2 2018 $6.78M 30 Jun 2018 10-Q 20 Aug 2018
Q1 2018 $18.3M 31 Mar 2018 10-Q/A 20 Aug 2018
Q4 2017 $18.8M 31 Dec 2017 10-K 26 Mar 2019
Q3 2017 $23.6M 30 Sep 2017 10-Q/A 20 Aug 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.